Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory G Burrows

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligandsGregory G Burrows
Ophthalmic Research|February 11, 2010
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitisGrazyna Adamus, Landon J Karren, Jeff Mooney, et al.
Investigative Ophthalmology & Visual Science|May 26, 2006
Treatment of autoimmune anterior uveitis with recombinant TCR ligandsGrazyna Adamus, Gregory G Burrows, Arthur A Vandenbark, et al.
Reviews in the Neurosciences|January 17, 2009
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosisHalina Offner, Sushmita Sinha, Chunhe Wang, et al.
Journal of Neuroimmunology|October 23, 2010
RTL therapy for multiple sclerosis: a Phase I clinical studyHalina Offner, Sushmita Sinha, Gregory G Burrows, et al.
Molecular Vision|September 15, 2012
Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons ratsGrazyna Adamus, Shaomei Wang, Madison Kyger, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
Plos One|July 14, 2011
RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNSSushmita Sinha, Lisa M Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injuryHalina Offner, Sandhya Subramanian, Chunhe Wang, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2007
Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic miceJason M Link, Cathleen M Rich, Maya Korat, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Current Drug Targets. Inflammation and Allergy|April 28, 2005
Systemic immunomodulation of autoimmune disease using MHC-derived recombinant TCR ligandsGregory G Burrows
Ophthalmic Research|February 11, 2010
A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitisGrazyna Adamus, Landon J Karren, Jeff Mooney, et al.
Investigative Ophthalmology & Visual Science|May 26, 2006
Treatment of autoimmune anterior uveitis with recombinant TCR ligandsGrazyna Adamus, Gregory G Burrows, Arthur A Vandenbark, et al.
Reviews in the Neurosciences|January 17, 2009
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosisHalina Offner, Sushmita Sinha, Chunhe Wang, et al.
Journal of Neuroimmunology|October 23, 2010
RTL therapy for multiple sclerosis: a Phase I clinical studyHalina Offner, Sushmita Sinha, Gregory G Burrows, et al.
Molecular Vision|September 15, 2012
Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons ratsGrazyna Adamus, Shaomei Wang, Madison Kyger, et al.
Investigative Ophthalmology & Visual Science|December 15, 2011
Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 miceGrazyna Adamus, Lori Brown, Shayne Andrew, et al.
Plos One|July 14, 2011
RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNSSushmita Sinha, Lisa M Miller, Sandhya Subramanian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 9, 2005
Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injuryHalina Offner, Sandhya Subramanian, Chunhe Wang, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2007
Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic miceJason M Link, Cathleen M Rich, Maya Korat, et al.
Pageof 5